المؤلفون: Pasello G; Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. giulia.pasello@iov.veneto.it.; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy. giulia.pasello@iov.veneto.it., Fabricio ASC; Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Del Bianco P; Clinical Research Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Salizzato V; Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. valentina.salizzato@iov.veneto.it., Favaretto A; Medical Oncology Unit, Ca' Foncello Hospital, AULSS 2, Treviso, Italy., Piccin L; Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Zustovich F; Medical Oncology Unit, AULSS 1 Dolomiti, Belluno, Italy., Fabozzi A; Medical Oncology 3, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., De Rossi C; Medical Oncology Unit, AULSS 3 Serenissima, Mestre-Venice, Italy., Pigozzo J; Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., De Nuzzo M; Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy., Cappelletto E; Regional Center for Biomarkers, Department of Clinical Pathology, AULSS3 Serenissima, Venice, Italy., Bonanno L; Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Palleschi D; Medical Oncology Unit, Ca' Foncello Hospital, AULSS 2, Treviso, Italy., De Salvo GL; Clinical Research Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Guarneri V; Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy., Gion M; Regional Center for Biomarkers, Department of Clinical Pathology, AULSS3 Serenissima, Venice, Italy., Chiarion-Sileni V; Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.

المصدر: Journal of translational medicine [J Transl Med] 2024 Mar 05; Vol. 22 (1), pp. 242. Date of Electronic Publication: 2024 Mar 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/drug therapy , Carcinoma, Non-Small-Cell Lung*/drug therapy , Lung Neoplasms*/drug therapy , Skin Neoplasms*, Female ; Male ; Humans ; Granulocyte-Macrophage Colony-Stimulating Factor ; Interleukin-10 ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Tumor Necrosis Factor-alpha ; Interleukin-4 ; Interleukin-6 ; Interleukin-8 ; Prospective Studies ; Cytokines ; Biomarkers

المؤلفون: Cappelletto E; Regional Center for Biomarkers, Department of Clinical Pathology, AULSS3 Serenissima, Venice, Italy., Fasiolo LT; Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Salizzato V; Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Piccin L; Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Fabozzi A; Medical Oncology 3, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Contato A; Regional Center for Biomarkers, Department of Clinical Pathology, AULSS3 Serenissima, Venice, Italy., Bianco PD; Clinical Research Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Pasello G; Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy., Chiarion-Sileni V; Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Gion M; Regional Center for Biomarkers, Department of Clinical Pathology, AULSS3 Serenissima, Venice, Italy., Fabricio ASC; Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.

المصدر: The International journal of biological markers [Int J Biol Markers] 2024 Mar; Vol. 39 (1), pp. 9-22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: SAGE Publishing Country of Publication: United States NLM ID: 8712411 Publication Model: Print Cited Medium: Internet ISSN: 1724-6008 (Electronic) Linking ISSN: 03936155 NLM ISO Abbreviation: Int J Biol Markers Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/therapy , Lung Neoplasms*/therapy, Humans ; Cytokines ; Interleukin-10 ; Chemokine CCL4 ; Chemokine CXCL10 ; Interleukin-2 ; Interleukin-4 ; Interleukin-5 ; Interleukin-8 ; Ligands ; Vascular Endothelial Growth Factor A ; Biomarkers

المؤلفون: Perez J; International Breast Cancer Center, Quiron Group, Barcelona, Spain.; Medical Department, Medica Scientia Innovation Research (MedSIR), Valencia, Spain., Garrigós L; International Breast Cancer Center, Quiron Group, Barcelona, Spain., Gion M; Quironsalud Group, Madrid, Spain.; Department of Medical Oncology, Hospital Universitario Ramón Y Cajal, Madrid, Spain., Jänne PA; Department of Medical Oncology, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Shitara K; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Siena S; Department of Oncology and Hematology-Oncology, Università Degli Studi Di Milano, Milan, Italy.; Niguarda Cancer Center Grande Ospedale Metropolitano Niguarda, Milan, Italy., Cortés J; International Breast Cancer Center, Quiron Group, Barcelona, Spain.; Medical Department, Medica Scientia Innovation Research (MedSIR), Valencia, Spain.; Department of Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.

المصدر: Expert opinion on biological therapy [Expert Opin Biol Ther] 2021 Jul; Vol. 21 (7), pp. 811-824. Date of Electronic Publication: 2021 Apr 01.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101125414 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7682 (Electronic) Linking ISSN: 14712598 NLM ISO Abbreviation: Expert Opin Biol Ther Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Carcinoma, Non-Small-Cell Lung* , Immunoconjugates* , Lung Neoplasms*/drug therapy, Camptothecin/analogs & derivatives ; Female ; Humans ; Receptor, ErbB-2 ; Trastuzumab/therapeutic use

المؤلفون: Gion M; Department of Cancer Medicine, Gustave Roussy, Villejuif, France; Hospital Ramon y Cajal, Madrid, Spain. Electronic address: mariagion@gmail.com., Remon J; Department of Cancer Medicine, Gustave Roussy, Villejuif, France. Electronic address: JORDI.REMON-MASIP@gustaveroussy.fr., Caramella C; Radiology Department, Gustave Roussy Cancer Campus, Villejuif, France. Electronic address: Caroline.CARAMELLA@gustaveroussy.fr., Soria JC; Department of Cancer Medicine, Gustave Roussy, Villejuif, France; University Paris-Sud, Orsay, France. Electronic address: Jean-Charles.Soria@gustaveroussy.fr., Besse B; Department of Cancer Medicine, Gustave Roussy, Villejuif, France; University Paris-Sud, Orsay, France. Electronic address: Benjamin.BESSE@gustaveroussy.fr.

المصدر: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2017 Jun; Vol. 108, pp. 72-74. Date of Electronic Publication: 2017 Feb 27.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*therapeutic use , Antineoplastic Agents, Immunological/*therapeutic use , Carcinoma, Non-Small-Cell Lung/*pathology , Lung Neoplasms/*pathology , Meningeal Neoplasms/*drug therapy , Meningeal Neoplasms/*secondary, Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal/adverse effects ; Antineoplastic Agents, Immunological/administration & dosage ; Antineoplastic Agents, Immunological/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Humans ; Magnetic Resonance Imaging ; Male ; Meningeal Neoplasms/diagnosis ; Middle Aged ; Molecular Targeted Therapy ; Nivolumab

المؤلفون: Gasparini G; Medical Oncology Unit, Azienda Ospedaliera, San Filippo Neri, Rome. gasparini.oncology@tiscalinet.it, Meo S, Comella G, Stani SC, Mariani L, Gamucci T, Avallone A, Lo Vullo S, Mansueto G, Bonginelli P, Gattuso D, Gion M

المصدر: Cancer journal (Sudbury, Mass.) [Cancer J] 2005 May-Jun; Vol. 11 (3), pp. 209-16.

نوع المنشور: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 100931981 Publication Model: Print Cited Medium: Print ISSN: 1528-9117 (Print) Linking ISSN: 15289117 NLM ISO Abbreviation: Cancer J Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Phytogenic/*therapeutic use , Carcinoma, Non-Small-Cell Lung/*drug therapy , Cyclooxygenase Inhibitors/*therapeutic use , Lung Neoplasms/*drug therapy , Paclitaxel/*therapeutic use , Pyrazoles/*therapeutic use , Sulfonamides/*therapeutic use, Administration, Oral ; Adult ; Aged ; Antineoplastic Agents, Phytogenic/administration & dosage ; Antineoplastic Agents, Phytogenic/adverse effects ; Biomarkers, Tumor/blood ; Carcinoma, Non-Small-Cell Lung/pathology ; Celecoxib ; Combined Modality Therapy ; Cyclooxygenase Inhibitors/administration & dosage ; Cyclooxygenase Inhibitors/adverse effects ; Drug Administration Schedule ; Drug Therapy, Combination ; Female ; Humans ; Infusions, Intravenous ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Paclitaxel/administration & dosage ; Paclitaxel/adverse effects ; Pyrazoles/administration & dosage ; Pyrazoles/adverse effects ; Sulfonamides/administration & dosage ; Sulfonamides/adverse effects ; Survival Analysis ; Treatment Outcome ; Vascular Endothelial Growth Factor A/blood

المؤلفون: Ferruzzi E; Regional Centre for the Study of Biological Markers of Malignancy, General Hospital, ULSS12 Venice, Italy., Franceschini R, Cazzolato G, Geroni C, Fowst C, Pastorino U, Tradati N, Tursi J, Dittadi R, Gion M

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2003 May; Vol. 39 (7), pp. 1019-29.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print Cited Medium: Print ISSN: 0959-8049 (Print) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor/*blood , Carcinoma, Non-Small-Cell Lung/*blood , Carcinoma, Squamous Cell/*blood , Glutathione/*blood , Glutathione Transferase/*blood , Head and Neck Neoplasms/*blood , Lung Neoplasms/*blood, Adult ; Aged ; Aged, 80 and over ; Carcinoma, Non-Small-Cell Lung/enzymology ; Carcinoma, Squamous Cell/enzymology ; Female ; Head and Neck Neoplasms/enzymology ; Humans ; Lung Neoplasms/enzymology ; Male ; Middle Aged

المؤلفون: Gion M, Dittadi R, Mione R, Pagan V, Busetto A

المصدر: The International journal of biological markers [Int J Biol Markers] 1994 Oct-Dec; Vol. 9 (4), pp. 258-9.

نوع المنشور: Letter

بيانات الدورية: Publisher: SAGE Publishing Country of Publication: United States NLM ID: 8712411 Publication Model: Print Cited Medium: Print ISSN: 0393-6155 (Print) Linking ISSN: 03936155 NLM ISO Abbreviation: Int J Biol Markers Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor/*analysis , Keratins/*analysis , Lung Neoplasms/*chemistry, Cytosol/chemistry ; Humans ; Immunoenzyme Techniques

المؤلفون: Correale M; Istituto Oncologico, Bari, Italy., Arnberg H, Blockx P, Bombardieri E, Castelli M, Encabo G, Gion M, Klapdor R, Martin M, Nilsson S, et. al.

المصدر: The International journal of biological markers [Int J Biol Markers] 1994 Oct-Dec; Vol. 9 (4), pp. 231-8.

نوع المنشور: Clinical Trial; Comparative Study; Journal Article; Multicenter Study

بيانات الدورية: Publisher: SAGE Publishing Country of Publication: United States NLM ID: 8712411 Publication Model: Print Cited Medium: Print ISSN: 0393-6155 (Print) Linking ISSN: 03936155 NLM ISO Abbreviation: Int J Biol Markers Subsets: MEDLINE

مواضيع طبية MeSH: Antigens, Neoplasm/*analysis , Biomarkers, Tumor/*analysis , Breast Neoplasms/*chemistry , Colorectal Neoplasms/*chemistry , Lung Neoplasms/*chemistry , Peptides/*analysis , Urinary Bladder Neoplasms/*chemistry, Antibodies, Monoclonal ; Breast Neoplasms/pathology ; Colorectal Neoplasms/pathology ; Enzyme-Linked Immunosorbent Assay ; Humans ; Immunoradiometric Assay ; Lung Neoplasms/pathology ; Pilot Projects ; Sensitivity and Specificity ; Tissue Polypeptide Antigen ; Urinary Bladder Neoplasms/pathology

المؤلفون: Dittadi R; Cancer for the Study of Biological Markers of Malignancy, Regional General Hospital, Venice, Italy., Gion M, Pagan V, Brazzale A, Del Maschio O, Bargossi A, Busetto A, Bruscagnin G

المصدر: British journal of cancer [Br J Cancer] 1991 Oct; Vol. 64 (4), pp. 741-4.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print Cited Medium: Print ISSN: 0007-0920 (Print) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung/*chemistry , ErbB Receptors/*analysis , Lung/*chemistry , Lung Neoplasms/*chemistry, Aged ; Humans ; Middle Aged